RLYB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rallybio Corp (RLYB) is not a strong buy for a beginner, long-term investor at this time. The lack of positive trading signals, weak financial performance, and absence of significant catalysts or news make it unsuitable for immediate investment.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 39.688, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level of 4.962, with key support at 4.495 and resistance at 5.429.
NULL identified. No significant news, trading trends, or positive financial developments.
Weak financial performance in Q3 2025, with revenue, net income, and EPS showing significant YoY declines. No recent insider or hedge fund activity. Technical indicators suggest bearish or neutral sentiment.
In Q3 2025, revenue dropped 29.10% YoY to $212,000. Net income fell 239.68% YoY to -$16,016,000. EPS decreased 238.46% YoY to 0.36. Gross margin remained flat at 100%.
No data on analyst ratings or price target changes.
